ici 204,219 has been researched along with 2019 Novel Coronavirus Disease in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naz, A | 1 |
| Asif, S | 1 |
| Alwutayd, KM | 1 |
| Sarfaraz, S | 1 |
| Abbasi, SW | 1 |
| Abbasi, A | 1 |
| Alenazi, AM | 1 |
| Hasan, ME | 1 |
| Citron, F | 1 |
| Perelli, L | 1 |
| Deem, AK | 1 |
| Genovese, G | 1 |
| Viale, A | 1 |
2 other studies available for ici 204,219 and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Repurposing FIASMAs against Acid Sphingomyelinase for COVID-19: A Computational Molecular Docking and Dynamic Simulation Approach.
Topics: Antiviral Agents; COVID-19; Drug Repositioning; Humans; Molecular Docking Simulation; Molecular Dyna | 2023 |
Leukotrienes, a potential target for Covid-19.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betaco | 2020 |